Cutera, Inc. (NASDAQ:CUTR ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Shelby Eckerman - Vice President of Finance Taylor Harris - Chief Executive Officer Stuart Drummond - Interim-Chief Financial Officer Conference Call Participants Jonathan Block - Stifel Anthony Vendetti - Maxim Group Macauley Kilbane - William Blair Operator Thank you for standing by. This is the conference operator.
Cutera (CUTR) came out with a quarterly loss of $1.85 per share versus the Zacks Consensus Estimate of a loss of $0.96. This compares to loss of $1.61 per share a year ago.
Cutera Inc. (CUTR, Financial) experienced a significant stock price decline of 5.14%, bringing its price to $0.751 per share. The trading volume reached 26,733 shares, with a turnover rate of 0.13% and a price fluctuation of 5.03%.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Taylor C. Harris CEO | NASDAQ (NGS) Exchange | 232109108 CUSIP |
| US Country | 430 Employees | - Last Dividend | - Last Split | 31 Mar 2004 IPO Date |
Cutera, Inc. is a global leader in the provision of aesthetic and dermatology solutions, catering primarily to medical professionals. Since its inception in 1998, the company has been at the forefront in developing, manufacturing, and marketing advanced energy-based product platforms. With a commitment to innovation and quality, Cutera, Inc. extends its product reach through direct sales and services, alongside a robust network of distributors and direct international sales operations. Headquartered in Brisbane, California, Cutera, Inc. consistently aims to address a wide array of skin concerns, enhancing the practice of medical aesthetics worldwide.
AviClear offers a revolutionary approach in the treatment of mild, moderate, and severe inflammatory acne vulgaris. It stands out as a distinct solution within Cutera's product lineup, providing patients with a clearer complexion without the drawbacks associated with traditional acne treatments.
Secret PRO combines fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling. This dual-action device is designed to rejuvenate the skin, offering solutions for texture, scar, and aging concerns with minimal downtime.
truFlex is introduced as a bio-electrical muscle stimulation device catering to patients across all fitness levels. It targets muscle toning and strengthening, representing Cutera's venture into the body sculpting domain with a focus on non-surgical options.
This is a versatile vascular and benign pigmented lesion treatment platform. excel V+ extends the capability to address a variety of skin concerns, including but not limited to rosacea, spider veins, and age spots, through its advanced laser technology.
truSculpt is a high-powered radio frequency system aimed at circumferential reduction, lipolysis, and deep tissue heating. The system is versatile, allowing treatment of all body and skin types, showcasing Cutera's commitment to inclusive aesthetic solutions.
Secret RF is a fractional RF microneedling device that leverages controlled RF energy to deliver heat into the deeper layers of the skin. The device is tailored for skin rejuvenation, specifically targeting signs of aging, acne scars, and texture irregularities.
The enlighten laser platform features a dual wavelength system optimized for the effective removal of multi-colored tattoos, in addition to treating benign pigmented lesions and acne scars. This underscores Cutera's technological innovation in laser treatments.
excel HR is Cutera's answer to hair removal challenges, offering a solution that is adaptable for all skin types. Its technology underlines a pain-reduced experience while ensuring efficacy across a broad spectrum of hair colors and types.
xeo is a multi-application platform designed for various aesthetic treatments, including unwanted hair removal, vascular lesion treatment, and skin revitalization. This platform epitomizes the versatility of Cutera's offerings, addressing a wide range of skin concerns with a single device.